BigBear.ai vs. Cerebras Systems: Which Technology Stock Is a Better Buy in 2026?

Cerebras Systems is favored over BigBear.ai based on FY2025 revenue growth of 75.7% to nearly $510.0 million and net income of $237.8 million, versus BigBear.ai's 19.3% revenue decline to $127.7 million and $293.9 million net loss. Cerebras' 46.6% net margin turnaround and G42 compute partnership support its growth case, though free cash flow was negative $392.8 million and its 70.7x P/S valuation reflects substantial execution risk. BigBear.ai remains constrained by customer concentration, with customers accounting for about 51% of revenue, negative $46.3 million free cash flow, and a class-action lawsuit tied to accounting restatements.

Analysis

CBRS is not a clean AI-infrastructure long despite its apparent operating leverage: a hardware vendor trading at an extreme revenue multiple must sustain both growth and gross-margin credibility while funding working capital, inventory, and cloud capacity. The key diligence item is cash conversion rather than reported earnings—negative free cash flow at this scale can force equity issuance or customer-financing arrangements before the business reaches self-funded scale. Any deceleration in large-customer orders would compress the multiple disproportionately because the market is underwriting a platform outcome, not a conventional semiconductor supplier outcome.

The non-obvious CBRS risk is strategic dependence on a small set of sovereign or hyperscale-backed compute buyers. That creates exposure to export-control changes, customer concentration, and lumpy acceptance/revenue-recognition cycles; it also gives AMZN, MSFT and NVDA leverage to compete through bundled cloud credits, proprietary silicon, and lower-cost financing rather than chip-level performance alone. Over 6-18 months, CBRS must prove that wafer-scale architecture creates durable total-cost-of-ownership advantages across inference as well as training, where NVDA's software ecosystem remains the incumbent moat.

BBAI should be valued as a distressed government-services/software hybrid until it demonstrates organic contract growth and normalized cash burn. Security-cleared personnel and procurement relationships may have scarcity value, but they do not protect equity holders if contract recompetes, stop-work orders, or litigation-related costs absorb liquidity. The more attractive second-order beneficiary of defense-AI procurement is likely established integrators such as PLTR, LDOS or CACI, which can bundle AI into existing programs and carry materially lower financing and execution risk.

Consensus appears too willing to frame this as a binary technology comparison. CBRS may be technically differentiated yet still be a poor stock at a premium valuation; BBAI may be optically cheap yet remain uninvestable without evidence that its commercial pivot improves revenue quality. Near-term news flow can favor CBRS, but the 1-3 month catalyst path is dominated by backlog, customer concentration, receivables, and capex disclosures rather than broad AI sentiment.

Key Decisions for Investors

• Do not chase CBRS on AI-momentum strength. Establish a watch alert for the next earnings release: only consider a long if revenue growth remains above 50%, operating cash-flow conversion improves materially, and management discloses diversified backlog/customer commitments. A failure on any of these metrics supports a 15-30% multiple-reset risk over 1-3 months.
• Preferred relative-value expression: long NVDA or MSFT / short CBRS in equal dollar amounts after a CBRS momentum-driven rally, using a 20-25% stop on the CBRS leg. NVDA/MSFT offer ecosystem and balance-sheet advantages; the trade wins if AI spending remains strong but hardware economics normalize. Avoid if CBRS secures independently verifiable multi-year, non-concentrated capacity commitments.
• Maintain BBAI as underweight/short only where borrow is available and position sizing accounts for high retail-driven volatility. Cover on evidence of two consecutive quarters of organic revenue growth, reduced cash burn, and resolution of accounting/litigation overhang; absent this, contract concentration can produce outsized downside on a single procurement update.
• For defense-AI exposure, favor a basket long PLTR, LDOS and CACI over BBAI for a 6-18 month horizon. Reassess if federal budget negotiations create broad continuing-resolution risk or if AI procurement shifts from prime-contractor awards toward smaller specialist vendors.